SUMMARY Streptokinase was infused into the ischemia-related coronary artery at a rate of 1000-2000 U/min for 15-95 minutes in 29 patients with acute myocardial infarction(AMI group) and in five patients with unstable angina pectoris (UAP group). Reopening of the completely obstructed vessel or increase of diameter at the site of subtotal lesions occurred in 22 AMI patients within 15-90 minutes of streptokinase infusion. In four of these patients, antegrade flow to the distal segments of the infarct vessel was seen after intracoronary nitroglycerin or sublingual nifedipine administration, which preceded streptoklinase infusion, and in two patients, streptokinase infusion was combined with recanalization by means of a guide wire. Chest pain was alleviated after reperfusion; ejection fraction was 50.5 ± 12% before and 54.6 ± 9% immediately after successful intracoronary lysis (p < 0.05). Repeat angiography, performed 25 ± 11 days after the acute intervention in 19 AMI patients, revealed reocclusion of the infarct vessel in one patient. Aortocoronary bypass surgery was performed electively in six AMI patients at varying intervals after successful lysis. Upon intraoperative inspection, the bulk of myocardium perfused by the recanalized vessel was found to be viable.
IN A PREVIOUS STUDY, coronary angiography performed in 18 medically treated infarct patients during the acute and chronic stage revealed spontaneous recanalization of the infarct vessel in 40% of the cases.' In another study, acutely occluded coronary arteries could be recanalized mechanically by use of guide wires and catheters in 10 patients.2 Repeat angiography in the chronic stage of myocardial infarction showed increases in diameter of the recanalization canal in six of these patients. Most likely, these findings indicate endogenous lysis of coronary artery thrombi. As reported in a third study, selective infusion of low doses of streptokinase into the infarct vessel resulted in rapid recanalization or increased luminal diameter in four of five patients with acute infarction. 3 In this report, we present the initial results and follow-up data of the first 29 patients with acute myocardial infarction (AMI) and five patients with unstable angina pectoris (UAP) who were treated by intracoronary streptokinase infusion. VOL 63, No 2, FEBRUARY 1981 the R waves in the infarct-related ECG leads). Ad- ditional criteria for rejection were age older than 75 years or severe associated diseases that would have precluded anticoagulation or subsequent bypass surgery.
Informed consent for the procedure was obtained from the patient and from an accompanying relative if possible. An i.v. infusion of NTG at a rate of 1.5-6 mg/hour was started in all patients in the emergency room shortly after admission, except in patient 10, who received i.v. dopamine, 1200 gtg/min, and high doses of i.v. norepinephrine. Biplane left ventriculography (patient 10 excepted) and coronary angiography were performed within 1.5-15.5 hours (mean 5.6 ± 4 hours) after the onset of the pain episode for which the patient was admitted to the hospital. Leftheart catheterization was performed as previously described. 6 At the beginning of the study a bolus of 10,000 U of heparin was administered intraarterially.
Acute Angiography and Intracoronary Interventions
The ischemia-related coronary artery was identified on the basis of electrocardiographic and angiographic criteria: 23 AMI patients had acute ST elevations; two AMI patients had symmetrical T-wave inversion (patients 20 and 21) and three AMI patients had downward-sloping ST depression (patients 13, 24 and 25). Coronary angiography revealed either a subtotal stenosis or occlusion of a corresponding vessel. In patient 13, in whom the ECG showed nonspecific ST-T changes, delayed clearing of contrast medium from the segment between the site of circumflex occlusion and the first proximal branch was taken as a sign of acute obstruction.7 In the UAP group, patient 33 had ST elevation in the inferior leads and severe narrowing of the right coronary artery, and patients 30-32 had symmetrical T-wave inversion in the left precordial chest leads and a high-degree stenosis of the left anterior descending coronary artery. In patient 34, who had a normal preangiography ECG and threevessel disease, only the circumflex lesion was subtotal.
Identification of the ischemia-related coronary artery was followed by premedication for intracoronary drug therapy: aspirin (1 g i.v.) was injected to prevent formation of platelet thrombi and corticosteroids (prednisolone 0.747 mg i.v. in most patients) were applied to avoid allergic reactions to streptokinase. The catheter that had been used for coronary angiography was carefully placed in a stable position in the ostium of the right or left main coronary artery. Direct contact of the catheter with the site of obstruction or subselective catheterization of the ischemiarelated vessel was avoided. A bolus of NTG (0.1-0.45 mg) was injected into the coronary artery,7 followed by repeat injections of contrast medium after 30 seconds and 3 minutes. Subsequently, patients 21-29 received 10 mg of sublingual nifedipine, and the coronary artery was opacified 5 minutes later. Streptokinase (Deutsche KABI GmbH; 250,000 U dissolved in 1 1 of normal saline solution) was infused into the ischemia-related main vessel at a rate of 2000 U/min through the coronary catheter. In patient 1, the rate of streptokinase infusion was 1000 U/min. In patients 1-17, streptokinase infusion was preceded by intracoronary injection of a bolus of streptokinase (10,000-20,000 U dissolved in 5 ml of normal saline). The soft tip of a 0.032-inch, movable-core guide wire was passed beyond the obstruction before streptokinase infusion in patient 2 and after 78 minutes of streptokinase infusion in patient 25. Streptokinase infusion was interrupted for repeat injection of contrast medium every 15 minutes or whenever there was a change of symptoms or ECG. (Leads I, II, III were monitored continuously throughout the study.) Arterial blood pressure was determined every 5 minutes.
The streptokinase infusion was terminated after 60 minutes in the majority of patients to avoid major alterations of coagulation factors. In patients 17-19, 23, 25 and 28 the duration of enzyme infusion was extended up to 95 minutes because the angiographic result did not seem satisfactory after 60 minutes or because the patient still complained of chest pain. In patients 2-4, 9, 16 and 20, the infusion was terminated earlier because reperfusion had been achieved and chest pain had subsided. The total dose of streptokinase was 128,000 i 36,000 U.
Follow-up Treatment
After completion of the streptokinase infusion, both coronary arteries were selectively visualized again and left ventriculography was repeated in 18 AMI patients.
In the coronary care unit, i.v. heparin was administered at a dose of 800-1200 U/hour for 4-7 days, followed by long-term anticoagulation with warfarin in the AMI patients in whom intracoronary lysis had been angiographically successful (with the exception of patient 5). Clotting factors were determined before and after streptokinase application, and CPK4 and CK-MB5 were determined hourly until they returned to normal.
Aortocoronary bypass surgery was performed at various intervals after the acute study in eight AMI and three UAP patients using standard techniques (table 1) . Intraaortic balloon counterpulsation was begun in patient 6 immediately after the acute study. In patient 10, the attempt to place a balloon catheter via the right and left femoral arteries during intracoronary lysis was unsuccessful due to narrowing of both iliac arteries.
Angiography was repeated 15-81 days after the acute study in 22 AMI patients (patients 1, 2, 13 and 27 after bypass surgery) and in three UAP patients.8 9 At restudy, all patients were being administered isosorbide dinitrate, fA blockers and warfarin. NTG bolus, guide-wire recanalization) or sublingual application of nifedipine was considered successful if antegrade flow beyond an initially total obstruction was shown or if there was clear-cut increase of diameter at the site of subtotal obstruction as determined by angiography. Local wall motion of the left ventricle was qualitatively assessed from biplane cineventriculograms."1' 12 Volumes were determined using the area-length method of Dodge et al. ' 3 Data are presented as mean ± SD. Differences between mean values were assessed by means of the paired t test.
Results

Acute Myocardial Infarction Group
Changes in Coronary Artery Morphology The initial injection of contrast medium showed total occlusion of the ischemia-related coronary artery in 20 patients and subtotal lesions in the remaining nine patients (table 1). All AMI patients had wall motion abnormalities corresponding to the perfusion area of the ischemia-related vessel.
Intracoronary streptokinase infusion alone or in combination with other measures was successful by angiographic criteria in 22 of 29 infarct patients (AMI, group); the acute interventions did not result in opening the infarct vessel or in an increase of diameter at the site of subtotal lesions in seven infarct patients (AMI2 group).
In five AMI, patients, interventions preceding streptokinase infusion were successful: Intracoronary application of NTG resulted in angiographically demonstrable changes in three patients; in patients 3 and 29, the initial total obstructions of the right and left anterior descending coronary arteries, respectively, were subtotal after intracoronary injection of NTG. There was more rapid and complete distal filling of the subtotally occluded circumflex branch in patient 4. After sublingual application of nifedipine, the initially total obstruction of the left anterior descending coronary artery in patient 21 was subtotal. In patient 2 there was delayed antegrade flow to the middle third of the left anterior descending coronary artery after a guide wire had been passed through the occlusion. In these five patients there was definite additional improvement in luminal diameter at the site of previous obstruction during streptokinase infusion.
In four patients with primary subtotal lesions (patients 12, 14, 20 and 24) that did not respond to intracoronary NTG or sublingual nifedipine, the degree of narrowing decreased during intracoronary lysis. In 12 patients with initially complete obstruction of the infarct vessel in whom the interventions preceding streptokinase application were without effect, antegrade flow was established during intracoronary streptokinase infusion (patients 5, 7, 8, 10, 11, 13, 15, [17] [18] [19] 22 and 27) (figs. 1 and 2).
The injection of contrast medium that showed patency was immediately preceded by a sudden onset of premature ventricular complexes in patients 5, 7, 13, 18, 19, 27 and 29; in the remaining patients with complete occlusions, no arrhythmias and patency were noted at the time of routine repeat opacification. Reopening of the infarct vessel was seen after 15-90 minutes of intracoronary streptokinase infusion. There seemed to be a loose correlation between lysis time required to achieve reperfusion and duration of symptoms before the acute intervention ( fig. 3 ). Subsequent injections of contrast medium showed progressive increases in luminal diameter at the site of previous obstruction, as well as improvement of antegrade flow ( fig. 1) . In patient 25, the obstruction of the right coronary artery appeared more convex after 78 minutes of streptokinase infusion, but antegrade flow to the distal vessel was seen only after a guide wire had been passed beyond the occlusion. This mechanical intervention was followed by streptokinase infusion for 15 minutes, and the vessel remained patent. The final contrast injection showed 80-90% lesions in the 22 AMI, patients in whom intracoronary lysis was successful and a filling defect, suggestive of thrombus, in one patient of this group ( fig. 2B ). Repeat angiography performed before hospital discharge 25 ± 11 days after the acute intervention in 19 of these patients revealed reocclusion of the infarct vessel in patient 13, no change in 13 patients and definite further improvement in luminal diameter at the site of the initial infarct lesion in patients 15, 17, 19, 25 and 27 ( fig. 2) .
The acute intervention was unsuccessful in seven AMI patients (AMI2 group). Patients 1, 9, 16 and 26 had subtotal lesions and patients 6, 23 and 28 had complete obstruction of the infarct vessel. Partial recanalization occurred during streptokinase infusion in two AMI2 patients with complete obstruction of the infarct vessel. In patient 23, the filling defect became more convex and was partially stained by dye; in patient 28, a 2.5-cm segment of the occluded right coronary artery was recanalized, but the infarct vessel remained obstructed distally in both patients. Repeat angiography performed 3 weeks after the acute intervention in the three AMI2 patients with complete occlusion showed patency of the infarct vessel in patients 6 and 23 and persistent obstruction in patient 28. Repeat angiography performed in the chronic stage in two AMI2 patients with subtotal lesions (patients 1 Chest pain did not improve in two of the three AMI2 patients with complete occlusion of the infarct vessel. The third patient of this subgroup received analgesic medication. The four AMI2 patients with subtotal obstruction of the infarct vessel became asymptomatic before intracoronary intervention after initiation of i.v. NTG therapy.
ECG Changes
ST elevation of more than I mV was present in 17 AMI1 patients before the acute study. ST elevation was unchanged in only one of these patients after completion of the streptokinase infusion and was reduced in seven patients. In eight patients, the ST-segment had returned to baseline. There were no follow-up ECGs in patient 10, who was in cardiogenic shock.
Two of the three AMI2 patients with complete obstruction of the infarct vessel had ST elevation that was unchanged after the acute study. The four AMI2 patients with subtotal lesions of the infarct vessel had elevated ST segments before the acute study that returned to the baseline after completion of the intervention.
Pathologic Q waves were present before the acute study in seven AMI1 patients. The ECG obtained after intracoronary lysis showed new Q waves in one AMI1 patient; development of Q waves in subsequent ECGs was noted in two additional AMI1 patients. Patho-logic Q waves did not disappear after reperfusion.
The admission ECG of one AMI2 patient with complete obstruction of the infarct vessel showed pathologic Q waves; the remaining two patients of this subgroup developed pathologic Q waves in the coronary care unit. Immediate or late development of new Q waves was not observed in the four AMI2 patients with subtotal lesions of the infarct vessel.
Complications and Hospital Course
In patient 10, who died 3 hours after reperfusion, systolic left ventricular pressure could not be raised above 60 mm Hg before intracoronary streptokinase application, despite maximal doses of vasopressors. Coronary angiography revealed occlusion of the left anterior descending and right coronary arteries and absence of collaterals. Streptokinase infusion into the right coronary artery resulted in patency within 15 minutes. Subsequently, left ventricular pressure rose transiently to 85 mm Hg. An intraaortic balloon catheter could not be passed beyond the iliac arteries due to peripheral atherosclerosis. Ventricular fibrillation occurred repeatedly before and after reperfusion.' The patient died in refractory cardiogenic shock. Autopsy revealed acute anteroseptal and inferior infarction, acute occlusion of the left anterior descending coronary artery and atheromatous narrowing of the right coronary artery with an intimal tear and remnants of an acute thrombus.
Patient 5, who was not placed on full-dose, longterm anticoagulants because of arterial hypertension, suffered an anteroseptal reinfarction 34 days after the acute study and died in cardiogenic shock. Patient 11 died suddenly 10 weeks after the acute intervention and 7 days after bypass surgery. Autopsy revealed fresh thrombotic occlusion of a vein graft. All other patients were alive and well at the time of submission of this paper.
In patients 2 and 5, surgical revision of a femoral artery puncture was necessary after the acute study due to local hemorrhage. Fibrinogen had fallen from 480 mg% to 450 mg% in patient 2 and from 600 mg% to 480 mg% in patient 5. After the acute intervention in both patients, thrombin time was more than 5 minutes.
Ventricular fibrillation, which occurred in patient 3 when a transvenous pacemaker wire was advanced into the right ventricle during the acute study, could be controlled by defibrillation.
The premature ventricular complexes that immediately preceded angiographic demonstration of reperfusion in seven patients subsided spontaneously within 10 minutes in six patients. In patient 29, the premature ventricular complexes were multifocal, refractory to i.v. xylocaine and persisted for 30 minutes. Three and one-half hours after reperfusion this patient had a short bout of ventricular fibrillation that stopped spontaneously. Patient 2 had ventricular fibrillation 18 hours after the acute study.
To date, aortocoronary bypass surgery has been performed within 1 day to 8 
Clotting Factors
Clotting factors were determined in all AMI patients (patient 10 excepted) and in all UAP patients (table 2). Systemic fibrinogen and plasminogen values decreased only slightly after intracoronary lysis. Fibrin monomer complexes were elevated before the study and normal after completion of lysis. Thrombin time and thromboplastin time, which were determined before administration of streptokinase but after intraarterial administration of heparin (10,000 U), were markedly prolonged immediately before and after lysis therapy and remained in a therapeutic range 12 hours later ( coronary artery appeared to be possible based on the acute electrocardiographic and angiographic findings. In patient 10, the admission ECG showed signs of an acute inferior and a remote anteroseptal infarction; the autopsy revealed acute necrosis of both the inferior and the anteroseptal wall. Rapid recanalization of occluded vessels and improvement of lumen at the site of high-degree lesions during intracoronary streptokinase infusion imply that fresh thrombotic material was present at the site of obstruction in 21 of 29 patients. Also, there was most likely thrombotic occlusion in the three AMI2 patients in whom antegrade flow was not established during the acute procedure: partial recanalization occurred during streptokinase administration in two of these patients, and repeat angiography performed in the chronic stage revealed patency of the infarct vessel in the third patient. Our findings are in agreement with those of most pathologists, who found fresh coronary thrombosis in the majority of patients with acute myocardial infarction." Thrombotic occlusion was usually seen at the site of high-degree atherosclerotic lesions in pathologic studies. In our patients, the narrowing that persisted after intracoronary lysis and was still present at repeat angiography in the chronic stage of infarction was most likely due to atherosclerosis.
Improved distal filling or patency of the infarct vessel after intracoronary application of NTG, which occurred in three AMI patients, may be due to an increase in caliber of the large conductive vessels,"5 or it may be evidence of spasm, as suggested by Oliva. The possibility of spasm cannot be ruled out in the vessels that failed to respond to intracoronary NTG. In patient 21 , for example, antegrade filling of the initially obstructed infarct vessel occurred after sublingual administration of nifedipine. In all four patients in whom there was possible evidence of coronary artery spasm, the subsequent infusion of streptokinase resulted in additional and more marked improvement of lumen.
Intracoronary infusion of streptokinase did not result in angiographically demonstrable changes in four AMI patients who had subtotal lesions or in all five UAP patients who also had subtotal lesions. Most likely, narrowing of the ischemia-related coronary artery was not due to fresh thrombotic material in these nine patients, and there was no evidence of coronary artery spasm.
Alleviation of Acute Myocardial Ischemia
In agreement with animal experiments, rapid decrease of ST-segment elevation was seen in the majority of patients after reperfusion. Decrease of ST elevation has been interpreted as indirect evidence of salvage of myocardium by some investigators,'8 and as possible consequence of accelerated cell necrosis by others.'7' 1 ' Rapid alleviation of ischemic pain during streptokinase infusion in AMI, patients could be explained by the same two mechanisms. Extension of cell necrosis seems unlikely, however, because ejection fraction was increased immediately after streptokinase infusion. Intraoperative inspection in six patients revealed the bulk of myocardium perfused by the recanalized vessels to be viable.
Persistence of chest pain throughout the acute study in the two AMI2 patients who had complete obstruction of the infarct vessel and did not receive opiates indicates that myocardial ischemia was not alleviated. In the four AMI2 patients and the five UAP patients who had subtotal lesions of the infarct vessel, chest pain was alleviated after reduction of preload and afterload by medical therapy. The ischemic episodes were probably caused by increased myocardial oxygen demand in the presence of high-degree fixed coronary artery lesions in these subgroups. Technical Aspects of Intracoronary Thrombolysis
The regimen of local lysis used in this study was successful in the 22 AMI, patients as judged by alleviation of symptoms and angiographic changes. Apparently, not all thrombotic material had been dissolved at the end of the acute intervention in some of these patients, as shown by the additional improvement of lumen during the chronic stage in five AMI, patients. Our technique was insufficient in three AMI2 patients in whom only partial or delayed recanalization of the infarct vessel was achieved.
In animal experiments, Kanmatsuse et al.1' showed that the efficiency of intracoronary thrombolysis depends upon the amount of lytic substance infused per minute and on the distance between the thrombus and the tip of the infusion catheter. In the present study, the infusion catheter was placed in the ostium of the right or left coronary artery. Distal placement or subselective catheterization of obstructed branches was not attempted for the sake of safety, rapidity and simplicity of the procedure. No 2, FEBRUARY 1981 the basis of experience with local lysis in peripheral vessels. 20 The total dose of streptokinase infusion was limited to a maximum of 220,000 U to avoid streptokinase-induced coagulation disorders, which would interfere with possible emergency surgery. In a preliminary study,21 no significant change of fibrinogen or plasminogen was seen after rapid infusion of a total dose of 50,000-100,000 U of streptokinase. However, there was a significant, albeit moderate, reduction of both fibrinogen and plasminogen after 275,000 U of streptokinase. In the present study, only minor decrease of systemic fibrinogen and plasminogen levels was observed. Bleeding from the arterial puncture site in two patients was due to heparinization, which resulted in marked prolongation of thrombin time, rather than to fibrinolytic therapy.
Reperfusion might be achieved more efficiently by various modifications of the technique, e.g., increase of streptokinase dosage, subselective infusion via small special catheters,'9 more aggressive use of mechanical devices or different thrombolytic substances. Each of these modifications could increase the risk of the intervention.
In animal experiments, sudden release of mechanical coronary artery occlusion frequently results in dangerous arrhythmias.22 Moschos et al.23 observed that serious arrhythmias were less frequent if reperfusion was achieved gradually by intracoronary lysis. In our patients, ventricular flutter or fibrillation did not occur immediately after reperfusion, although ventricular premature complexes that were not present before the acute study developed in seven patients. In one, patient 29, the premature ventricular complexes were multifocal and lasted for 30 minutes. It cannot be determined if ventricular fibrillation occurring 3 1½2 hours later in this patient and 18 hours after the acute study in patient 2 were related to reperfusion.
Aortocoronary Bypass Surgery After Intracoronary Thrombolysis
Reperfusion in acute myocardial infarction has been achieved by aortocoronary bypass surgery.24 26 Intracoronary interventions performed immediately after diagnostic angiography resulted in more rapid reperfusion in 22 patients of this study. Optimal follow-up management of these patients has not been defined. There is a risk of reocclusion at the site of the persisting high-degree lesion. Reocclusion was documented angiographically in one patient in our series. It has been our policy to attempt stabilization on medical therapy, including anticoagulants, and to perform elective aortocoronary bypass surgery as soon as signs of myocardial ischemia reoccur. Aortocoronary bypass surgery was performed within 7 days after reperfusion in three patients without perioperative complications; the operation has been performed or scheduled in an additional seven patients of this group in the chronic stage of myocardial infarction.
The treatment of patients in whom the intracoronary interventions were unsuccessful followed the same guidelines. plicated the assessment of infarct size. Moreover, the time period was too brief to permit evaluation of the effects of coronary reperfusion on survival. The goal of the present investigation was to determine if coronary artery reperfusion at either 1 or 3 hours after coronary artery occlusion exerted beneficial effects in the conscious animal if the animals were sacrificed 1 week after occlusion. In this manner, the longer-term salutary effects of the intervention could be assessed in the absence of acute complicating factors, e.g., hemorrhagic infarction, which is known
